Improving Treatment of Opioid Use Disorder Through Development of Novel Formulations of Buprenorphine
WebcastFaculty
OVERVIEW
Improving Treatment of Opioid Use Disorder Through Development of Novel Formulations of Buprenorphine is organized by UK HealthCare CECentral and will be held during Apr 09, 2017 - Apr 08, 2020.
The target audience for this medical event is Healthcare professionals prescribing opiates interested in reducing addiction and discovering treatment options for addicted patients. This CME Conference has been approved for a maximum of 0.50 CME.
Conference Objectives :
Upon completion of this educational activity, participants will be able to:
• Review buprenorphine efficacy
• Discuss barriers to buprenorphine use
• Describe novel buprenorphine formulations currently in development
• Review available data on these products
• Discuss characteristics for patient-treatment matching
Additional details will be posted as soon as they are available.
The target audience for this medical event is Healthcare professionals prescribing opiates interested in reducing addiction and discovering treatment options for addicted patients. This CME Conference has been approved for a maximum of 0.50 CME.
Conference Objectives :
Upon completion of this educational activity, participants will be able to:
• Review buprenorphine efficacy
• Discuss barriers to buprenorphine use
• Describe novel buprenorphine formulations currently in development
• Review available data on these products
• Discuss characteristics for patient-treatment matching
Additional details will be posted as soon as they are available.
SPECIALITIES
PsychiatryRELATED ONLINE COURSES
3 Hours
...
...
Quick Links